ABSTRACT

Background
Among the most basic measures of respiratory function is the total lung capacity (TLC). TLC is the pulmonary gas volume at maximal lung inflation, which is the sum of the volume of gas that can be exhaled -the vital capacity (VC)-and the volume of gas that cannot -the residual volume (RV). Determination of VC requires only spirometry whereas determination of RV or TLC requires body plethysmography, gas dilution or washout, or thoracic imaging, each of which is more complex than spirometry, and none of which is suited to routine office practice, population screening, or community medicine. To fill this gap, we describe here a new approach to determine TLC without plethysmography.
Methods
In a heterogeneous population of 434 volunteers (265 male, 169 female; 201 healthy, 170 with airflow obstruction, and 63 with ventilatory restriction), we determined TLC in the standard fashion using conventional body plethysmography (TLCpleth). In the same individuals, we also determined TLC in a novel fashion using the MiniBox TM (TLCMB). To obtain TLCMB, population-based data from traditional spirometry together with flow-interruption transients were subjected to data mining and machine-learning to create for each individual subject an unbiased statistical determination of TLC.
Results
For the combined heterogeneous population, we found TLCpleth = 1.02TLCMB -0.091 L, adjusted r 2 =0.824. For the heterogeneous population as a whole, and for each subpopulation, TLCMB closely tracked TLCpleth. For 26 healthy subjects measured on different days, the coefficient of variation for repeated measurements in was 3.3% for TLCpleth versus 1.6% for TLCMB .
Conclusions
These results establish the validity and potential utility of a new method for rapid, accurate, and repeatable determination of TLC in a heterogeneous patient population, but without the need of a plethysmograph.
INTRODUCTION
The most common test of pulmonary function is spirometry, in which the volume of air flowing into and out of the respiratory system is measured directly. Spirometry can quantify volume differentials such as tidal volume (VT), forced vital capacity (FVC), or expiratory reserve volume (ERV), but cannot measure absolute volumes such as residual volume (RV), functional residual capacity (FRC), or total lung capacity (TLC). Absolute thoracic gas volumes (TGVs), such as RV, FRC, and TLC are useful in the diagnosis and management of respiratory system diseases, but their measurement requires technologies that are more complex and labor intensive than spirometry. Accordingly, RV, FRC, and TLC are often not available in adult or pediatric office practices.
To measure absolute lung volumes, the ATS/ERS Consensus Statement identifies five methods: whole body plethysmography, multi-breath helium dilution, nitrogen wash-out, computed tomography, and chest radiography. 1 Among these, body plethysmography is used most commonly and is widely regarded as the gold standard. [1] [2] [3] [4] [5] [6] [7] [8] Since its inception by Dubois in 1956 9 , body plethysmography has remained simple in principle but inherently complex, capital intensive, and physically imposing in practice. The plethysmograph can be uncomfortable or intimidating for the patient enclosed within it and, moreover, is dependent upon a skilled technician for calibration, operation and maintenance. Gas dilution and gas washout are wellestablished alternatives to body plethysmography, but each presents its own technical challenges.
For these reasons, investigators have explored alternative avenues to determine absolute lung volumes by other means, but with no success. Respiratory system impedance, even when extended to a wide range of forcing frequencies, has been shown to be inadequate to infer absolute lung volumes in the individual subject. [10] [11] [12] [13] [14] [15] [16] [17] Similarly, forced expiratory maneuvers have been shown to be inadequate. 18 These failures may be attributable in part to the fact that the dynamics of gas distribution within the human lung are complex, and especially so in obstructive lung disease. Moreover, data interpretation in these approaches often rests upon fitting data to idealized mathematical models wherein there exists a wide range of TGV values that might fit the data equally well. When this happens, no useful determination of TGV can be inferred and the problem of mathematical inference is said to be non-unique or ill-posed.
To determine TLC in the individual subject without using a plethysmograph, here we take a different approach. Across a heterogeneous population of volunteers we measured traditional spirometry together with flow-interruption transients using a MiniBox TM , described below. In the same individuals we also measured TLC using traditional body plethysmography (TLCpleth). To obtain an unbiased statistical determination of TLC from corresponding MiniBox TM data (TLCMB) in the individual subject, we then used data mining and machinelearning. Because TLCMB for the individual subject is based on population-based data mining and machine-learning rather than a direct physiological measurement, its main advantage is that it rests upon no idealizing assumptions concerning respiratory system structure or function.
Nevertheless, in any given subject this approach was able to determine TLC in a fashion that is accurate and repeatable when compared to TLCpleth but without the need of a plethysmograph.
METHODS
The study comprised three parts. First, in a heterogeneous population of 300 qualified volunteers, as described below, we measured TLC in the conventional manner using body plethysmography. In these same volunteers, we measured conventional spirometry and flow- The population comprised three groups (Table 1 ): 1) healthy subjects; 2) subjects with airflow obstruction, such as chronic obstructive lung disease (COPD) or asthma and with varying severity level (mild, moderate, and severe); and 3) subjects with restrictive ventilatory disorders.
Patients were recruited from the Lung Function Laboratory at each institution. In each case, disease severity was defined by the criteria in ATS/ERS guidelines. 23 Subjects were considered eligible if they: a) provided informed consent; b) were at least 18 years of age; and c) were cooperative and capable of following instructions. Healthy subjects were eligible if they: a) never smoked; b) had no known history of respiratory, cardiovascular, hepatic, renal or metabolic disease; c) had a BMI < 35 kg/m 2 ; d) had no persistent (lasting greater than 3 days) respiratory symptoms during the last 12 months (e.g., dyspnea, chronic cough, wheezing or phlegm); and e) had no history suggesting upper respiratory infection during the three weeks prior to testing. Non-healthy subjects were eligible if they had a documented obstructive or restrictive respiratory disorder.
Subjects were excluded from the study if they: a) were pregnant at the time of the study; b) had performed any significant physical activity that has resulted in breathlessness during 1 hour prior to the study; c) had a tracheostomy; d) were unable to satisfactorily perform routine, full lung function testing including body plethysmography (e.g., due to claustrophobia or inability to perform the panting maneuver required for plethysmography); e) were unable or unwilling to give informed consent; or f) were unable to complete the protocol.
For each subject, all measurements were made in the same laboratory, by the same technician, and were competed within two hours. The technician also recorded the subject's gender, date of birth, height, weight, and summary medical history. Subjects first performed spirometry using either the spirometer associated with the body plethysmograph or the hand-held spirometer associated with the MiniBox. For each participating laboratory, spirometry measurements were performed in accordance with the manufacturers' user manuals and in a manner typical for that laboratory, as assessed by the local laboratory director. By design, spirometry measurements corresponded to real-world circumstances so as to include real-world methodological variability. That being the case, these measurements did not necessarily conform to ATS/ERS guidelines. 24 For example, in retrospective analysis we found that not all spirometry efforts continued for at least 6 seconds. 
N-fold cross-validation.
To assess the predictive ability of the model, 10-fold cross-validation was used on the dataset of 300 subjects. 21, 22 The dataset was randomly divided using 10-fold for 50 times and the samples for each fold were selected randomly for each time. A 5-fold and leave-one-out cross validation (LOOCV) was also performed as comparison.
Prospective validation. Last, we performed an independent prospective study to further validate the TLCMB equation. In a prospective heterogeneous cohort of 134 additional volunteers not previously studied (Table 1) , we repeated the protocol of MiniBox and body plethysmography measurements. We then used the new MiniBox data and the TLCMB equation derived from the initial cohort of 300 subjects to calculate TLCMB and compared it to TLCpleth in the prospective cohort of 134 subjects.
RESULTS
Subject characteristics.
A total of 564 subjects were enrolled, of whom 4 were unable to complete the protocol and 126 were disqualified based on quality assurance criteria. There were not any adverse events. The final qualified dataset comprised 300 subjects in the first cohort and 134 subjects in the prospective cohort (Table 1) . Both cohorts included healthy individuals and patients with a range of diseases and a range of disease severities. To examine differences between results from both methods and their dependence on lung size, we performed Bland-Altman analyses. 30 In the population as a whole ( Figure 2E Post hoc statistical analysis determined that the predictive contribution of both spirometry and flow interruption transients were statistically significant (p<0.01) and that spirometry contributed a majority of the predictive power.
Day-to-day repeatability of TLC MB . From the initial 300 subject pool, we selected 26 healthy subjects at random to assess day-to-day repeatability with a minimum of 12 days between the measurements. Day-to-day repeatability was expressed as a coefficient of variation (CV; Figure   4 ). For TLCMB, the CV was 1.6% whereas for TLCpleth the CV was 3.3%.
DISCUSSION
Based upon spirometry and flow interruption data taken together, here we apply data mining and machine learning to population-based observations in order to determine TLC in the individual subject. Within a highly heterogeneous population of subjects, we show that this approach yields accurate and reproducible determinations of TLC in the individual subject.
Unlike the TLCpleth, the TLCMB is not calculated based upon a physical principle or a mechanistic respiratory system model; physiological mechanisms were not a consideration.
Instead, here we used inductive statistics and nonlinear systems identification, reminiscent of other applications of big data, to infer a relationship from which we could then make an accurate determination of TLC in the individual subject.
Summary of clinical results.
Across the entire population studied, across specific patient subgroups, and across a prospective heterogeneous population, our results show that TLCMB is accurate compared to TLCpleth. Among our prospective cohort of 134 subjects, who were healthy or had varying severities of obstructive and restrictive diseases, TLCMB correlated well with TLCpleth (adjusted r 2 = 0.795) with a slope close to unity (slope = 0.977) (Figure 3) .
Furthermore, in a subset of healthy subjects, TLCMB was appreciably more repeatable from dayto-day than was TLCpleth ( Figure 4 ), suggesting that TLCMB might be particularly useful in longitudinal clinical management.
Comparison to helium dilution and CT imaging. How does TLCMB compare to other
alternative technologies, such as gas dilution or computed tomography (CT), to measure absolute lung volumes? In a cohort of healthy, obstructive, and restrictive subjects, O'Donnell et al. 6 performed Bland-Altman analyses to compare TLC measured using both helium dilution (TLCHe) and CT imaging (TLCCT) to TLC measured using plethysmography (TLCpleth). 6 For TLCHe and TLCCT, the analysis showed coefficients of variation of 18.9% and 15.6%, respectively, together with systematic biases and trends for increasing error in subjects with larger TLCs (Figure 5B and 5C). Although we studied a different cohort, and results may therefore not be strictly comparable, Bland-Altman analysis of TLCMB showed a coefficient of variation of 12.3% in our prospective cohort (N = 134 subjects), no systematic bias, and no trend of increasing error with increasing TLC ( Figure 5A ). While each of these technologies is based on a different mechanism-of-action, and thus is not expected to mimic plethysmographic TLC faithfully in all subjects, TLCMB values had the smallest deviations from those of TLCpleth.
Limitations:
The TLCMB approach is limited in at least three important ways. First, TLCMB is a population-based statistical approach. To the extent that specific populations might differ, different data training sets might be required. For example, pediatric populations, geriatric populations, or specific racial populations might require different training sets. Second, the flow interruption parameters improved the accuracy of TLCMB determinations by an amount that was small but nonetheless was highly significant statistically (p<0.01) . Third, TLCMB is designed to recapitulate as closely as possible TLCpleth. But TLCpleth is itself subject to artifacts and is known to be an imperfect measure of TLC. [31] [32] [33] [34] As such, any biases or errors inherent to TLCpleth are necessarily inherent in TLCMB.
Conclusions. The NHLBI, ATS, and ERS have encouraged innovation in technologies to
measure absolute lung volumes so as to attain improved accuracy, ease of use, and rapidity of testing 35 , and have recommended rigorous testing to ensure no substantial differences in results compared with standard techniques. In all sub-populations tested, the MiniBox TM performed in a manner that compared favorably with body plethysmography. Also, the day-to-day variability of TLCMB was smaller than that of TLCs derived from helium dilution, CT imaging, or body plethysmography. Accordingly, this study establishes the validity of TLCMB for rapid, accurate, and repeatable determination of TLC in a heterogeneous population of healthy adults and those with respiratory system diseases. healthy subjects, the TLCMB day-to-day repeatability was 1.6% compared to 3.3% for body plethysmograph. 
